PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
01 May 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

Sanofi to Divest European Generics Business in Deal Worth $2.4 Billion

Global investment firm Advent to acquire and invest in Sanofi's European generics business, Zentiva, to boost its position in European market.
/ read more /


A Perspective on the Topical Delivery of Macromolecules

The authors review the potential of delivering aptamers to the skin, with evidence that therapeutically relevant levels can be reached in both the epidermis and dermis.
/ read more /

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe
advertisement

Industry News

CRISPR Shows Promise for Enhancing Gene Therapy

Scientists at Washington University School of Medicine in St. Louis have developed a new method that could help increase the long-term effectiveness of gene therapy.
/ read more /


CDER Publishes Drug Safety Report

FDA's Center for Drug Evaluation and Research has published its second annual report on key safety programs and activities.
/ read more /


More Industry News
advertisement

Regulatory News

EMA and the Netherlands Finalize Seat Agreement

EMA and its new host country have finalized the terms of the agency's relocation to Amsterdam.
/ read more /


FDA Seeks to Advance Treatments for Opioid Use Disorder

The agency has released new guidance on the development of new medication-assisted treatments for opioid dependence.
/ read more /


More Regulatory News

Bio/Pharma News

FDA Grants Roche Breakthrough Therapy Designation on Haemophilia Drug

FDA has granted breakthrough therapy designation to Roche's drug for treating haemophilia A in patients without factor VIII inhibitors.
/ read more /


J&J, BMS Team Up on Cardiovascular Therapies

Johnson & Johnson's Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
/ read more /


More Bio/Pharma News

Supplier News

Catalent to Invest in New Drug Development Center of Excellence

The company will add a new $5-million drug development center of excellence at its facility and headquarters in Somerset, NJ.
/ read more /

 

AMRI Wins NIH Contract Renewal for Neurotherapeutics

The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
/ read more /


More Supplier News

FEATURED TOPICS

SUPPLY CHAIN

Managing Pharmaceutical Recalls with Automation

How warehouse execution systems can help in case of a drug recall.
/ read more /

 

EXCIPIENTS

The Real Complexity of Excipient Composition

This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
/ read more /

FORMULATION

Delivering High-Concentration Protein Formulations

The high viscosity of highly concentrated monoclonal antibody formulations not only presents processing and storage difficulties, but also formulation and delivery challenges.
/ read more /

MANUFACTURING

Pharma 4.0

Pharma 4.0 envisions highly efficient automated processes, which could be continuous, batch, or a hybrid of these, driven by an integrated manufacturing control strategy.
/ read more /


Product Profile

Wickham Laboratories Ltd–

Microbiology & toxicology contract testing for the pharmaceutical and medical device industries
Wickham Laboratories Ltd is a trusted name in the pharmaceutical and medical device industries with over 50 years of experience in contract testing, research and consultancy.
/ Read more/


Event Profile

Chemspec Europe 2018 - The 33rd International Exhibition for Fine & Speciality Chemicals

Date: 20th – 21st June 2018
Venue: Koelnmesse, Cologne, Germany
Chemspec Europe is a renowned market place for sourcing and trading of fine and speciality chemicals for a wide range of applications and industry sectors, including pharmaceuticals and bio-based chemicals.
/ Read more/


ON DEMAND WEBCASTS

Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression
On Demand
Learn more


Dose Design: Bridging Early- and Late-Phase Development
On Demand
Learn more


Improve Data Transparency and Collaboration Across your Manufacturing Network
On Demand
Learn more


Events

BIO International Convention

Boston, US

4–7 June 2018

ACHEMA 2018

Frankfurt am Main, Germany

11–15 June 2018


more events

eBOOKS

Vaccines Development and Manufacturing 2017

Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise